Targeting polarized phenotype of microglia via IL6/JAK2/STAT3 signaling to reduce NSCLC brain metastasis

Yu Jin1, Yalin Kang1, Minghuan Wang2

  • 1Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei Province, China.

Insights

Interleukin-6 (IL6) produced by non-small cell lung cancer (NSCLC) cells activates microglia, promoting brain metastasis. Targeting the IL6/JAK2/STAT3 pathway may inhibit NSCLC brain metastasis.

Area of Science:

  • Neuro-oncology
  • Cancer biology
  • Immunology

Background:

  • Tumor-associated macrophages, including microglia in the brain, are implicated in cancer metastasis.
  • The precise mechanisms by which microglia promote non-small cell lung cancer (NSCLC) brain metastasis are not fully understood.

Purpose of the Study:

  • To elucidate the communication between brain-metastatic NSCLC cells and microglia.
  • To identify key molecular regulators driving NSCLC brain metastasis.

Main Methods:

  • Co-culture system of brain-metastatic NSCLC cells (A549-F3) and microglia.
  • Single-cell RNA-sequencing and transcriptome analysis.
  • Analysis of clinical samples and The Cancer Genome Atlas (TCGA) data.

Main Results:

  • IL6 was identified as a key mediator secreted by metastatic NSCLC cells.
  • IL6 induced an anti-inflammatory phenotype in microglia via the JAK2/STAT3 signaling pathway.
  • This microglial activation promoted NSCLC cell colonization in the brain.
  • Higher serum IL6 levels correlated with increased brain metastasis in patients.
  • Lower IL6 levels in NSCLC patients were associated with longer overall survival.

Conclusions:

  • The IL6/JAK2/STAT3 signaling axis in microglia plays a critical role in promoting NSCLC brain metastasis.
  • Targeting this pathway presents a potential therapeutic strategy for inhibiting brain metastasis in NSCLC.

Related Concept Videos